Genevieve Marie Gerhard, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dendritic Cells | 1 | 2021 | 2746 | 0.330 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3947 | 0.280 |
Why?
|
Splanchnic Circulation | 1 | 2024 | 122 | 0.220 |
Why?
|
Kupffer Cells | 1 | 2021 | 144 | 0.180 |
Why?
|
Antigens, Ly | 1 | 2020 | 297 | 0.160 |
Why?
|
Myeloproliferative Disorders | 1 | 2024 | 615 | 0.150 |
Why?
|
Neutrophils | 2 | 2021 | 3771 | 0.150 |
Why?
|
src-Family Kinases | 1 | 2018 | 538 | 0.130 |
Why?
|
Neoplasms | 2 | 2021 | 22350 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1327 | 0.120 |
Why?
|
Neoplasms, Experimental | 1 | 2018 | 1230 | 0.110 |
Why?
|
Hemorrhage | 1 | 2024 | 3463 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8505 | 0.100 |
Why?
|
Phosphoproteins | 1 | 2018 | 2445 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1511 | 0.080 |
Why?
|
Anticoagulants | 1 | 2024 | 4863 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2880 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2018 | 2898 | 0.070 |
Why?
|
Fatty Liver | 1 | 2013 | 807 | 0.070 |
Why?
|
Liver | 1 | 2021 | 7560 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4752 | 0.060 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9521 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3459 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2741 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2013 | 1959 | 0.050 |
Why?
|
Obesity, Morbid | 1 | 2013 | 1293 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4772 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9071 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2024 | 1168 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13455 | 0.030 |
Why?
|
GTPase-Activating Proteins | 1 | 2018 | 464 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1837 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2627 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 17060 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18065 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3606 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2850 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2013 | 1739 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9548 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4884 | 0.020 |
Why?
|
Animals | 4 | 2021 | 168721 | 0.020 |
Why?
|
Humans | 6 | 2024 | 766011 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7425 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10429 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24299 | 0.010 |
Why?
|
Mice | 2 | 2019 | 81786 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10262 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22320 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10031 | 0.010 |
Why?
|
Transcription Factors | 1 | 2018 | 12123 | 0.010 |
Why?
|
Male | 3 | 2024 | 363808 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65236 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74870 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 223058 | 0.010 |
Why?
|
Adult | 2 | 2024 | 223109 | 0.010 |
Why?
|
Aged | 1 | 2024 | 171233 | 0.010 |
Why?
|
Female | 2 | 2024 | 396159 | 0.010 |
Why?
|